Cevimeline Hydrochloride
NDC 33342-216, Cevimeline Hydrochloride, capsule, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-216
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206808
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-216 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEVIMELINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-216-11 | 33342021611 | 100 CAPSULE in 1 BOTTLE (33342-216-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/990887c1-11ce-4a73-83b4-0ffc5a900c85NADAC price for package 33342021611
GET /v1/drugs/nadac/33342021611
Use it
Look up 33342-216 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-216 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-216. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.